Berardi Francesco, Abate Carmen, Ferorelli Savina, Colabufo Nicola Antonio, Perrone Roberto
Dipartimento Farmacochimico, Università degli Studi di Bari, via E. Orabona 4, 70125 Bari, Italy.
Cent Nerv Syst Agents Med Chem. 2009 Sep;9(3):205-19. doi: 10.2174/1871524910909030205.
Herein the evolution in the development of new sigma (sigma) receptor ligands since the middle '90s by our research group is reported. In the effort to contribute to the identification of the structural features for high-affinity ligands selective versus serotonin, dopamine and other CNS-related receptors, two general classes of (naphthalene)alkylamine compounds were prepared and explored, with the aim of addressing the affinities toward the two recognized sigma receptor subtypes. The common template of these compounds was mainly an unsubstituted or methoxy-substituted naphthalene or tetralin nucleus, linked by an alkyl spacer to a substituted piperazine or piperidine ring. The design of new ligands was thought keeping in mind their possible application as PET diagnostic tools and fluorescence tools. High-affinity sigma(2) receptor ligands were found among N-cyclohexylpiperazine derivatives, such as 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (3) (PB 28), when they were assayed in radioligand binding with [(3)H]-DTG in rat liver. Unfortunately, these ligands were all devoid of a significant selectivity relative to sigma(1) receptor whose binding was assayed with (+)-[(3)H]-pentazocine in guinea pig brain. Nevertheless, compound 3 had previously shown to be 40-fold selective with a slightly different binding method in animals' tissues. Moreover, it demonstrated 46-fold and 59-fold sigma(2) versus sigma(1) receptor binding selectivity in MCF7 and MCF7 ADR tumor cell lines respectively. In the class of piperazines, also high-affinity sigma(1) receptor ligands were found, possibly due to the presence of a double N-atom and an additional reverse mode of binding. Piperidine derivatives were investigated as high-affinity and selective sigma(1) receptor ligands leading to some 3,3-dimethylpiperidines such as 3,3-dimethyl-1-[3-(6-methoxynaphthalen-1-yl)propyl]piperidine (69) which resulted to be highly selective relative to the sigma(2) receptor. For the best ligands, functional assays were conducted in order to investigate agonist/antagonist activity. The effect of chirality in the intermediate methyl-alkyl chain was explored for a class of 4-methylpiperidines linked to some (4-chlorophenoxy)alkyl moieties, and compound (-)-(S)-92 emerged as the most selective sigma(1) relative to sigma(2) receptor ligand.
本文报道了自20世纪90年代中期以来我们研究小组在新型σ(西格玛)受体配体开发方面的进展。为了有助于确定对5-羟色胺、多巴胺和其他中枢神经系统相关受体具有选择性的高亲和力配体的结构特征,我们制备并研究了两类(萘)烷基胺化合物,目的是研究它们对两种已确认的σ受体亚型的亲和力。这些化合物的共同模板主要是未取代或甲氧基取代的萘或四氢萘核,通过烷基间隔基与取代的哌嗪或哌啶环相连。在设计新配体时考虑到了它们作为正电子发射断层扫描(PET)诊断工具和荧光工具的可能应用。在N-环己基哌嗪衍生物中发现了高亲和力的σ2受体配体,例如1-环己基-4-[3-(5-甲氧基-1,2,3,4-四氢萘-1-基)丙基]哌嗪(3)(PB 28),当在大鼠肝脏中用[3H]-DTG进行放射性配体结合测定时。不幸的是,相对于用(+)-[3H]-喷他佐辛在豚鼠脑中测定的σ1受体,这些配体都没有显著的选择性。然而,化合物3先前已证明在动物组织中采用略有不同的结合方法时具有40倍的选择性。此外,它在MCF7和MCF7 ADR肿瘤细胞系中分别显示出相对于σ1受体的46倍和59倍的σ2受体结合选择性。在哌嗪类中,也发现了高亲和力的σ1受体配体,这可能是由于存在双氮原子和额外的反向结合模式。对哌啶衍生物作为高亲和力和选择性的σ1受体配体进行了研究,得到了一些3,3-二甲基哌啶,如3,3-二甲基-1-[3-(6-甲氧基萘-1-基)丙基]哌啶(69)相对σ2受体具有高度选择性。对于最佳配体,进行了功能测定以研究激动剂/拮抗剂活性。对于一类与一些(4-氯苯氧基)烷基部分相连的4-甲基哌啶,研究了中间甲基-烷基链中手性的影响,化合物(-)-(S)-92成为相对于σ2受体最具选择性的σ1受体配体。